 | TRACON Pharmaceuticals, Inc. | |||
| NCM : TCON || Location: United States | ||||
$2.08-0.03 (-1.42%) |
0.12 M | 2.0 - 2.14 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 0.037 M |
| March 15, 2024 | 1.897 M |
| Feb. 29, 2024 | 0.449 M |
| Feb. 15, 2024 | 0.856 M |
| Jan. 31, 2024 | 1.221 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.08 | 0.01 | 112.25% |
| 09/30/2023 | -0.07 | 0.29 | 537.41% |
| 06/30/2023 | -0.10 | 0.22 | 315.69% |
| 03/31/2023 | -0.27 | -0.36 | -35.75% |
| 12/31/2022 | -0.28 | -0.31 | -12.56% |
TCON Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 2.275M | Shares Float | 2.082M |
| Short Float | 0.037M | Market Cap | 4.80M |
| Institution ownership | 11.66% | Insider ownership | 2.595% |
| Earnings Date | 05/08/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -2.20 | Forward EPS | -3.43 |